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ABSTRACT
Several arboviruses have emerged and/or re-emerged in North, Central and South-
American countries. Viruses from some regions of Africa and Asia, such as the Zika and 
Chikungunya virus have been introduced in new continents causing major public health 
problems. The aim of this study was to investigate the presence of RNA from Zika, Dengue 
and Chikungunya viruses in symptomatic patients from Rondonia, where the epidemiological 
profile is still little known, by one-step real-time RT-PCR. The main clinical signs and 
symtoms were fever (51.2%), headache (78%), chills (6.1%), pruritus (12.2%), exanthema 
(20.1%), arthralgia (35.3%), myalgia (26.8%) and retro-orbital pain (19.5%). Serum from 
164 symptomatic patients were collected and tested for RNA of Zika, Dengue types 1 to 
4 and Chikungunya viruses, in addition to antibodies against Dengue NS1 antigen. Direct 
microscopy for Malaria was also performed. Only ZIKV RNA was detected in 4.3% of the 
patients, and in the remaining 95.7% of the patients RNA for Zika, Dengue and Chikungunya 
viruses were not detected. This finding is intriguing as the region has been endemic for Dengue 
for a long time and more recently for Chikungunya virus as well. The results indicated that 
medical and molecular parameters obtained were suitable to describe the first report of 
symptomatic Zika infections in this region. Furthermore, the low rate of detection, compared 
to clinical signs and symptoms as the solely diagnosis criteria, suggests that molecular assays 
for detection of viruses or other pathogens that cause similar symptoms should be used and 
the corresponding diseases could be included in the compulsory notification list.
KEYWORDS: Zika. Chikungunya. Dengue. One-step real-time RT-PCR. Diagnostic. 
Arboviruses. 
INTRODUCTION 
Climate conditions together with large populations of mosquitoes from the genera 
Aedes sp. and Anopheles sp. in the Western Brazilian Amazon lead to the perfect 
environment for the maintenance of arboviruses and protozoa transmission cycles. 
Outbreaks of Dengue virus (DENV), Yellow Fever virus (YFV), Oropouche virus 
(OROV), Mayaro virus (MAYV) and the Plasmodium sp. protozoa parasites have 
already been reported in this region1-4.
The Zika virus (ZIKV) was first isolated in 1947 from a monkey in Uganda and 
sporadic infections were subsequently identified in humans. In 2007, the virus was 
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found to be widespread among patients presenting with 
flu-like symptomatology during an outbreak in the Yap 
Island of the Federated States of Micronesia. The subsequent 
increased incidence of patients with microcephaly or Guillain-
Barré Syndrome in Brazil has been intensively investigated 
and the resulting data have established an association between 
ZIKV infections and neurological disorders5-7.
Infection with the DENV normally leads to fever and 
flu-like signs and symptoms, but can also be fatal in some 
cases8,9. Based on the epidemiological investigations 
reported to the World Health Organization, an estimated 
50-100 million cases occur annually in more than 
100 endemic countries, which indicates that half of the 
world’s population is at risk9.
Chikungunya virus (CHIKV) infection was first reported 
in 1952 in Southern Tanzania. Chikungunya fever is 
characterized by joint pains and high fever. The virus has 
recently arrived in Brazil (2014), and from the first report 
to the second half of 2017, approximately 300,000 cases 
have been reported, and 40% of Brazilian municipalities 
had confirmed cases10,11.
Vector-borne diseases have been a major challenge 
for public health, with mosquitoes being the main vectors 
of hundreds of microorganisms around the world12. The 
ecological and environmental conditions of the Amazon 
region favor the abundant presence of several species, 
including those that are potential vectors of human 
pathogens13.
Arboviruses have been a significant and constant threat due 
to the ease of adaptation of these viruses to new environments 
and their capacity to infect both vertebrates and invertebrate 
hosts. However, the anthropogenic environmental factors, 
such as disorganized urbanization, population displacement 
and the precariousness of basic sanitation, have favored the 
transmission and spread of these viruses14.
The aim of this study was to investigate the presence 
of main arboviruses spreading in Brazil (ZIKV, DENV 
and CHIKV) in patients with symptoms suggestive of 
arboviral disease, who lived in Rondonia during the first 
half of 2017. In summary, to date, this study provided the 
first epidemiological data on patients in this region, in 
whom RNA from ZIKV were identified. It is suggested that 
different protocols for the diagnosis of arbovirus infections 
should be combined in order to develop an improved 
algorithm to identify specific pathogens.
MATERIAL AND METHODS
Study location 
The study was developed at the Ambulatory of Malaria 
Outpatient Center for Tropical Medicine (CEPEM), located at 
BR 364, Km 3.5 in the city of Porto Velho, an agency linked 
to the State Department of Health (SESAU). The outpatient 
clinic is a reference center in malaria, attending hundreds of 
people with characteristic symptoms of the infection.
Samples
This study was approved by the local Research Ethics 
Committee (1.474.102CEP/2016/CEPEM). Whole blood 
samples were collected during the first half of 2017. For 
this study, serum samples from symptomatic patients were 
used and there was no laboratory evidence of the presence 
of Plasmodium sp. according to the direct microscopy 
investigation. In the first moment, a medical consultation 
was carried out to investigate the clinical data and identify 
the symptoms in these patients. Individuals over 12 years of 
age and both sexes, whose symptoms had a clinical course 
of up to five days, were included. The participant must also 
been agreed to receive periodic telephone calls and other 
electronic media contacts. Exclusion criteria were patients 
who do not have samples for laboratory and immunological 
characterization, indigenous patients and patients from 
other vulnerable groups.
RNA extraction
Viral RNA was extracted from 140 µL of serum samples 
by the QIAamp® Viral RNA Mini Kit (QIAGEN, Germany), 
according to the manufacturer’s instructions. RNA was 
eluted in 60 µL of the AVE buffer. 
Real-time RT-PCR
The RNA samples were tested for the presence of ZIKV; 
DENV serotypes 1, 2, 3, and 4; and CHIKV by a one-step 
real-time RT-PCR Kit (Biomol ZDC, Instituto de Biologia 
Molecular do Parana, Brazil), following the manufacturer’s 
instructions. Reactions were performed in an Applied 
Biosystems 7500 Real-Time PCR apparatus, as follows: 
51 °C for 30 min, 95 °C for 15 min, 40 cycles of 95 °C 
for 15 s, and 60 °C for 1 min. Reactions were considered 
positive when the threshold cycle was ≤ 36 for the virus 
analyzed and ≤ 28 for the internal control. 
DENV NS1 antigen testing
Serum samples were tested using the Platelia DENV 
NS1 AG (BIO-RAD, USA), an enzyme immunoassay for 
qualitative or semiquantitative detection of the NS1 antigen 
in human serum or plasma.
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Direct microscopy for malaria
Thick blood smears were stained with Giemsa which is 
the gold standard method for malaria diagnosis. Each blood 
smear was examined for the presence of Plasmodium by 
experienced technicians.
Statistical analysis
Data were entered into a database in Excel. The 
prevalences were analyzed with the WinEpi on-line package 
(Universidad de Zaragoza, Spain) and were presented as 
absolute values, with 95% confidence intervals (95% CIs). 
All statistical analyses were performed using the Prism® 
7.01 software for Windows™ (GraphPad Software, San 
Diego, CA). In all cases, p values < 0.05 were considered 
statistically significant.
RESULTS
A total of 164 samples were collected during the first 
half of 2017, from patients whose symptoms were mostly 
self-declared. During the anamnesis, the main relevant signs 
and symptoms reported by patients were: headache 78/164 
(78%), fever 84/164 (51.2%), arthralgia 58/164 (35.3%), 
myalgia 44/164 (26.8%), exanthema 33/164 (20.1%), retro-
orbital pain 32/164 (19.5%), pruritus 20/164 (12.2%), chills 
10/164 (6.1%) and conjunctivitis 7/164 (4.3%). Correlations 
between signs and symptoms of ZIKV-positive or negative 
patients are shown in Table 1.
Among the signs and symptoms reported by patients 
with viremia, only conjunctivitis had a statistical relevance 
(OR=12.16, 95% CI, 1.88-78.63, p=0.03), with a positive 
correlation between conjunctivitis and positivity for ZIKV, 
although only two cases had conjunctivitis. 
RNA from the serum samples of 164 patients were tested 
by real-time RT-PCR. Amplification results revealed that 7 
(4.3%) samples were positive only for ZIKV, and 157 were 
negative for all DENV serotypes, CHIKV and ZIKV viruses. 
Negative real-time RT-PCR results were validated by the 
internal control (Figure 1). All RNA samples amplified the 
internal control sequence (an endogenous human transcript), 
ensuring that these samples were not degraded and that the 
negative results were true negatives. The serological test for 
NS1 DENV antigen was negative for all serum samples. The 
microscopic evaluation of 164 peripheral blood smears was 
negative for malaria infection. In addition, the specificity of 
the real-time RT-PCR assay (Kit Biomol ZDC) for ZIKV, 
DENV and CHIKV was assessed by testing samples known 
to be positive for Plasmodium falciparum; MAYV, YFV 
and OROV; as well as ZIKV, DENV1, DENV2, DENV3, 
DENV4 and CHIKV. Data showed specific amplifications 
only, confirming the absence of cross-reactivity with the 
other evaluated pathogens. Assays were validated by the 
positive control supplied by the manufacturer (Figure 2). 
DISCUSSION
Infections caused by arboviruses and Plasmodium 
sp. occur in the same geographical regions due to the 
association between the climate and the presence of the 
vectors Aedes sp. and Anopheles sp., respectively. Patients 
with these infections present similar signs and symptoms, 
including chills, fever and headache, which may be mild 
and difficult to recognize1,12-14. In this study, considering the 
signs and symptoms reported by patients with viremia, only 
conjunctivitis was more common in ZIKV-positive cases, 
with 28.6% of patients with ZIKV infection presenting 
the symptom, corroborating results described in the 
literature15,16. Although conjunctivitis is reported in cases 
Table 1 - Signs and symptoms reported by patients.
Signs and symptoms
Positive ZIKV Negative ZIKV
p value OR (95% CI)
n=7 (%) n=157 (%)
Fever 5 71.4 79 50.3 0.274 2.47 (0.46 -13.11)
Arthralgia 4 57.1 54 34.4 0.245 2.54 (0.55-11.78)
Myalgia 3 42.9 41 26.1 0.387 2.12 (0.45-9.89)
Exanthema 3 42.9 30 19.1 0.146 3.17 (0.67-14.95)
Itching 2 28.6 18 11.5 0.204 3.09 (0.56-17.12)
Retro-Orbital Pain 3 42.9 29 18.5 0.135 3.31 (0.70-15.61)
Headache 3 42.9 75 47.8 1.000 0.82 (0.18-3.79)
Chills 0 0.0 10 6.4 1.000 0.94 (0.05-17.56)
Conjunctivitis 2 28.6 5 3.2 0.030 12.16 (1.88-78.63)
OR - Odds ratio; CI - Confidence interval.
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of ZIKV, it is not pathognomonic of this infection, as it has 
already been described in cases of DENV infection16, and 
has been observed in this study in 3.2% of ZIKV, DENV 
and CHIKV-negative cases, in infections probably caused 
by other pathogens.
One hundred and sixty-four patients presenting with 
symptomatology suggestive of arboviral infections were 
evaluated by medical, molecular and microscopic methods 
and, in this study, the first cases of symptomatic ZIKV 
infections were identified in Rondonia State, by a one-step 
real-time RT-PCR assay, after a worldwide explosive 
outbreak of the virus in 2015. 
The Epidemiological Bulletin from the Secretariat of 
Health Surveillance, Ministry of Health17, reported that the 
DENV prevalence in Rondonia State during 2017, based 
only on clinical signs and symptoms, was of 1,807 cases. 
For ZIKV and CHIKV, the numbers were 101 and 163, 
respectively. However, in this study, the detection rate of viral 
ZIKV RNA was 4.3% in the same region. Thus, our results 
suggest that the notification based only on epidemiological 
criteria and clinical symptomatology is unsuitable as 
diagnoses are not always confirmed by laboratory tests. Our 
cohort was composed of only symptomatic patients, and the 
number of ZIKV confirmed cases was low. To circumvent 
this problem, we suggest the use of molecular diagnostic 
protocols to assess the etiologic agents of arboviruses and 
other pathogens circulating in Brazil.
The nucleic acid assay ZDC BioMol kit (IBMP) used to 
detect RNA from ZIKV, DENV and CHIKV was effective 
in a previous epidemiological study, using different types 
of biological specimens such as urine and saliva samples, 
demonstrating that is an important tool for identification 
and differentiation of these arboviruses18.
Several surveillance strategies have been carried out for 
ZIKV, DENV and CHIKV infections in some localities in 
Northern Brazil. However, no screening study for ZIKV had 
been previously performed in Rondonia State. Currently, 
there are ongoing surveys on DENV and more recently on 
CHIKV fever (e.g., first description of CHIKV in Amapa 
State)19.
Figure 1 - Amplification profile depicting the threshold cycles 
(Cts) of positive patients and negative ones: A) Red line: positive 
ZIKV patient; B) Blue line: a negative patient to ZIKV, showing 
only the amplification of the internal control. 
Figure 2 - Amplification profiles depicting the Cts (on the abscissa axis) of positive samples for ZIKV, CHIKV, and DENV and the 
controls supplied by the Kit Biomol ZDC: A) Zika; B) Chikungunya; C) Dengue 1 and Dengue 4; D) Dengue 2 and Dengue 3. The 
amplification profiles of the studied viruses are represented in red or turquoise, while the controls are always represented in blue. 
The emitted fluorescence threshold (on the ordinate axis) for Zika is 0.5; for Dengue 1 and the Control is 0.2; for Dengue 2 is 0.5 
and for Dengue 3 and 4 is 0.4 and for Chikungunya is 1.
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The time lapse from the first molecular detection of 
ZIKV in Rondonia State to the first reported detection of 
autochthonous ZIKV in Brazil20 suggests that this virus is 
in the process of spreading in this region, as previously 
described for DENV and CHIKV. 
The small number of studies, together with the difficulty 
of identifying ZIKV, may be associated with geographic 
characteristics of the region. In addition, the co-circulation 
of other arboviruses, such as DENV, CHIKV, MAYV 
and OROV, which have overlapping symptoms to ZIKV 
infection (low fever, pruritus and cutaneous rash), may pose 
an additional challenge to understand the epidemiology 
of ZIKV infection in Rondonia State. Furthermore, the 
literature describes that the percentage of Zika asymptomatic 
or mild symptomatic cases is approximately 80% and this 
factor could be associated with our symptomatic cohort21,22. 
It is worth noting that DENV was not detected in this 
study, even by serological and molecular methods and 
considering that the region is endemic to this virus23.
Our new findings are of paramount importance to public 
health authorities, as ZIKV infections, as observed mainly in 
the Northeast region, has been responsible for the occurrence 
of complicated neurological syndromes in Brazil24. Due 
to the dispersion of specific ZIKV vectors throughout the 
country, in addition to the other major arboviruses, molecular 
screening should be considered as an important tool for 
monitoring patients with acute febrile diseases. Finally, the 
low rate of detection of ZIKV-infected individuals (7/164) 
and the absence of positive cases for DENV, CHIKV and 
Plasmodium sp. infections suggest that other pathogens have 
been circulating in this area. Because several outbreaks of 
arboviruses infections in the Rondonia have been reported, 
especially of DENV23, medical and molecular investigations 
for new arboviruses that are spreading throughout this region 
are needed. The list of new viruses should include the West 
Nile virus (WNV), MAYV, YFV and OROV.
CONCLUSION
To the best of our knowledge, this study described the 
first molecular evidence of human symptomatic ZIKV 
infections in Rondonia, a region considered highly endemic 
for arboviruses. As the signs and symptoms presented 
by the investigated population are similar to those of 
other arboviruses, an accurate laboratory scenario for the 
molecular screening of the main circulating arboviruses in 
our region is of prime importance.
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